0001209191-23-022874.txt : 20230404
0001209191-23-022874.hdr.sgml : 20230404
20230404173130
ACCESSION NUMBER: 0001209191-23-022874
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230331
FILED AS OF DATE: 20230404
DATE AS OF CHANGE: 20230404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jacobsen John R.
CENTRAL INDEX KEY: 0001880979
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40794
FILM NUMBER: 23799689
MAIL ADDRESS:
STREET 1: C/O DICE THERAPEUTICS, INC.
STREET 2: 279 E. GRAND AVENUE, SUITE 300, LOBBY B
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DICE Therapeutics, Inc.
CENTRAL INDEX KEY: 0001645569
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472286244
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 EAST JAMIE COURT
STREET 2: SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-566-1402
MAIL ADDRESS:
STREET 1: 400 EAST JAMIE COURT
STREET 2: SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: DiCE MOLECULES HOLDINGS, LLC
DATE OF NAME CHANGE: 20180725
FORMER COMPANY:
FORMER CONFORMED NAME: DiCE Molecules Holdings, LLC
DATE OF NAME CHANGE: 20150617
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-31
0
0001645569
DICE Therapeutics, Inc.
DICE
0001880979
Jacobsen John R.
C/O DICE THERAPEUTICS, INC.
400 EAST JAMIE COURT, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
CSO
0
Common Stock
2023-03-31
4
S
0
773
30.00
D
182639
D
The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 27, 2022.
/s/ Scott Robertson as attorney-in-fact for John R. Jacobsen
2023-04-04